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Introduction: Transfer of glucose across the human placenta is directly proportional to maternal glucose
concentrations even when these are well above the physiological range. This study investigates the
relationship between maternal and fetal glucose concentrations and transfer across the placenta.
Methods: Transfer of D-glucose, 3H-3-o-methyl-D-glucose (3H-3MG) and 14C-L-glucose across the isolated
perfused human placental cotyledon was determined for maternal and fetal arterial D-glucose concen-
trations between 0 and 20 mmol/l.
Results: Clearance of 3H-3MG or 14C-L-glucose was not affected by maternal or fetal D-glucose concen-
trations in either circulation.
Discussion: Based on the arterial glucose concentrations and the reported KM for GLUT1, the transfer of
D-glucose and 3H-3MG would be expected to show signs of saturation as D-glucose concentrations
increased but this did not occur. One explanation for this is that incomplete mixing of maternal blood
and the rate of diffusion across unstirred layers may lower the effective concentration of glucose at the
microvillous membrane and subsequently at the basal membrane. Uncertainties about the afﬁnity of
GLUT1 for glucose, both outside and inside the cell, may also contribute to the difference between the
predicted and observed kinetics.
Conclusion: These factors may therefore help explain why the observed and predicted kinetics differ and
they emphasise the importance of understanding the function of transport proteins in their physiological
context. The development of a computational model of glucose transfer may improve our understanding
of how the determinants of placental glucose transfer interact and function as a system.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-SA license.1. Introduction
Placental glucose transfer is essential to sustain fetal growth and
metabolism. Insufﬁcient glucose transfer will result in fetal growth
restriction (FGR) while too much is associated with fetal macro-
somia [1]. FGR and macrosomia are associated with complications
at birth and an increased burden of chronic diseases in adulthood
[2]. As such, it is important to understand factors that determine
glucose availability to the fetus in pregnancies with normal and
abnormal maternal glucose levels.
Glucose transport across themicrovillous (MVM) and basal (BM)
membranes of the human placental syncytiotrophoblast at term
has been shown to be a transporter mediated process [3]. It is
thought that glucose transfer is predominantly mediated by the
transporter GLUT1 (SLC2A1) which mediates facilitated diffusionfax: þ44 (0)2380795255.
ml2@soton.ac.uk (R.M. Lewis).
r Ltd. Open access under CC BY-NC-SA[3,4]. GLUT1 levels are lower on the BM which also has a smaller
surface area and, as a result, is thought to be rate-limiting for
placental glucose transfer [4]. Glucose transporters other than
GLUT1 may play important roles earlier in gestation, especially
GLUT3 [5,6]. The consensus KM for D-glucose transport by GLUT1 in
human erythrocytes is reported to be around 3 mmol/l although
lower and higher KM values have been reported, ranging from 1 to
17 mmol/l [7,8]. Glucose uptake by human placental MVM and BM
membrane vesicles is very rapid suggesting a high capacity for
glucose transport in the placenta [9]. Net glucose transfer across the
placenta will be the sum of paracellular and transcellular routes,
less any metabolised in the placenta. Although the paracellular
route across the syncytiotrophoblast is poorly deﬁned, it has been
demonstrated using L-glucose which is not transported by glucose
transporters [8,10,11].
The rate of glucose transfer across the humanplacenta is thought
to be primarily determined by thematernal to fetal glucose gradient
and transfer is directly proportional to this gradient up to maternal
glucose concentrations well above physiological [10,12,13]. Evi-
dence of transporter saturation in the perfused placenta has been
reported with glucose concentrations above 20 mmol/l suggesting license.
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reported for GLUT1 [3]. Maternal and fetal blood ﬂow will maintain
the concentration gradient by delivering glucose enriched blood
to the maternal side and removing the glucose transported to the
fetal circulation. Evidence that glucose transfer is ﬂow-limited is
consistentwith the idea that glucose transfer increases linearly with
maternalefetal glucose gradients [14]. This is interesting as a high
afﬁnity transporter such as GLUT1, which is believed to have a KM
below physiological glucose concentrations, would be expected to
be increasingly independent of maternal glucose concentrations as
they rise above the KM as illustrated in Fig. 1A. If there are more
transporters in the membrane then Vmax will be higher and the
capacity for glucose transfer across the placenta will be greater.
However, increasing Vmax will not change the glucose concentration
at which transporter saturation will occur (Fig. 1B).
Given the difference between the observed glucose transfer in
the human placenta and what would be predicted based on the
kinetics of GLUT1, we explored the extent to which glucose transfer
is transporter-limited. We also addressed the role of paracellular
glucose transfer in the human placenta.
2. Methods
Human placentas from uncomplicated term deliveries were obtained immedi-
ately after delivery from Princess Anne Maternity Hospital. Ethical approval was
given by the South and West Hants Local Research Ethical Committee.
3. Placental perfusion methodology
Placentas were perfused using the methodology of Schneider
[15] as adapted in our laboratory [16]. All placentas used for the
studies had a fetal arterial ﬂow rate recovery of 95% or greater.
Earle’s Bicarbonate Buffer (EBB, 1.8 mM CaCl2, 0.4 mM MgSO4,
116.4 mM NaCl, 5.4 mM KCl, 26.2 mM NaHCO3, 0.9 mM NaH2PO4
and a variable concentration of glucose as stated below) gassed
with 5% CO2 and 95% O2 was perfused through the fetal catheter
going into the chorionic plate fetal artery at 6 ml/min and the
ﬁve maternal catheters at 14 ml/min using a roller pump. Buffers
containing D-glucose, 14C-L-glucose and 3H-3-o-methyl-D-glucose0.00
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Fig. 1. The predicted effect of KM and Vmax on glucose transport based on simple
Michaelis Menten Kinetics. A, The effect of KM on glucose uptake using the KMs for
GLUT1-4 as examples [7]. Glucose transfer by GLUTs with a lower KM would be less
dependent on maternal glucose concentration. B, Glucose uptake is directly propor-
tional to Vmax but only proportional to maternal glucose levels where these are less
than KM. Note that the KM for all curves is 3 mmol/l (dotted line) regardless of the Vmax.(3H-3MG) (Perkin Elmer, Massachusetts, USA), were then
perfused as described below. When sampling approximately
1.5 ml of venous exudate was collected from maternal and fetal
venous outﬂows. At the end of the experiments, the perfused
mass of placental cotyledon that assumed a white colour was
obtained by trimming off the non-perfused tissue, then blotted
and weighed.
4. Glucose perfusions
In initial experiments increasing concentrations of D-glucose
were perfused through the maternal artery (from 0 to 18 mmol/l in
3 mmol/l steps for 20 min each) with no glucose added to the fetal
catheters going into the chorionic plate fetal artery.
Subsequently, experiments were performed using 0.8 mCi/l of
14C-L-glucose as a measure of paracellular diffusion and 8 mCi/l 3H-
3MGwere perfused into the maternal intervillous space or the fetal
artery. L-glucose is not transported by GLUT1 [8]. The non-
metabolisable glucose analogue 3MG is reported to have a KM of
1.8 mmol/l in human erythrocytes in linewith the consensus values
for the KM of D-glucose [17], although a higher KM is reported in
Xenopus oocytes of 17.6 mmol/l for 3MGwhich is again comparable
to the KM D-glucose of 17 mmol/l in this system [8]. In the maternal-
side tracer experiments maternal and fetal arterial D-glucose con-
centrations were: 0:0, 3:0, 6:0, 9:0, 9:3, 6:3, 3:3, 0:3, 0:6, 3:6, 6:6,
9:6 and 12:6 (maternal:fetal (mmol/l)) for 20 min at each step. In
the fetal tracer experiments maternal and fetal arterial D-glucose
concentrationwere: 0:3, 3:3, 6:3, 9:3, 9:6, 6:6, 3:6, 0:6, 0:9, 3:9, 6:9,
9:9, 15:9 and 15:20 (maternal:fetal (mmol/l)) for 20 min at each
step. Maternal and fetal venous samples were analysed by liquid
scintillation counting (PackardePerkin Elmer, Massachusetts USA)
and an enzymatic glucose assay (Alpha Laboratories, Eastleigh, UK)
according to the manufacturer’s instructions.
4.1. Analysis and statistics
Clearance was calculated so that transfer from maternal to fetal
and fetal to maternal circulations could be compared. Clearance of
3H-3MG or 14C-L-glucose from one circulation to the other was
calculated using the formula clearance ¼ [VR].FR/[AD]. Where
[VR] ¼ recipient arterial tracer activity (cpm), FR ¼ recipient circu-
lation ﬂow rate, [AD] ¼ donor circulation arterial tracer activity
(cpm).
Using simple Michaelis Menten Kinetics, predicted transport
curves for GLUT1, 2, 3 and 4 were generated using literature KM
values for each transporter (Fig. 1A) [7]. This calculation assumed
that donor side glucose concentrations were homogeneous and
equal to the arterial concentration. Michaelis Menten Kinetics were
determined using the following formula: v0 ¼ Vmax[S]/(KMþ[S])
where v0 is the initial rate, [S] is the substrate concentration, KM is
the substrate concentration at which there is the half maximal ﬂux
and Vmax the maximal rate of uptake. Where predictions are
compared to data the Vmax of the prediction was adjusted so that
the predicted and experimental data aligned in the early part of the
curve.
Transporter-mediated clearance was calculated by subtracting
clearance of L-glucose (representing paracellular glucose transfer)
from clearance of 3MG (which is transferred by both paracellular
diffusion and transcellular transport).
Maternal venous to fetal venous and fetal venous to maternal
venous ratios were calculated by dividing the venous concentration
in the recipient circulation by that in the donor circulation (the
circulation into which the tracer or glucose was added).
Statistical analyses were carried out using PASW SPSS19 (IBM,
Chicago, IL, USA). Clearance of 3H-3MG and L-glucosewere analysed
P.E. Day et al. / Placenta 34 (2013) 953e958 955by univariate analysis of variance with maternal arterial D-glucose
concentration, fetal arterial D-glucose concentration and donor
circulation as ﬁxed factors. All data are presented as mean and
standard error of the mean (SEM). A P value of less than 0.05 was
considered to be statistically signiﬁcant.
5. Results
In the maternal side tracer perfusion experiments mean (SEM)
fetal ﬂow recoverywas 6.0 (0.03) ml/min and cotyledonweight was
32.2 (8.3) g. In the fetal side tracer perfusion experiments mean
(SEM) fetal ﬂow recovery was 5.9 (0.03) ml/min and cotyledon
weight was 35.6 (4.4) g. There was no signiﬁcant difference in
cotyledon weight or ﬂow between the groups. In experiments
where tracer was added to the maternal circulation average tracer
recoveries (mean (SEM)) were 94 (3.9) % for 14C-L-glucose and 96
(3.1) % for 3H-3MG. In experiments where tracer was added to the
fetal circulation average tracer recoveries were 102 (2.4) % for 14C-L-
glucose and 104 (2.1) % for 3H-3MG.
5.1. Predicted glucose transfer kinetics
Predicted glucose transfer based on simple Michaelis Menten
kinetics were calculated for increasing KM (Fig. 1A) and Vmax values
(Fig. 1B).
5.2. Glucose transfer to the fetal vein
Transfer of D-glucose from the maternal circulation to the fetal
vein (venous concentration  ﬂow rate) was positively correlated
to maternal arterial D-glucose concentration, n ¼ 5 placentas
(Fig. 2). The curve of the line for D-glucose transfer was signiﬁcantly
different from that predicted by Michaelis Menten Kinetics for
GLUT1 with a KM of 3 mmol/l (P < 0.01). As glucose concentrations
in the artery may be higher than those at the membrane we
calculated how low the glucose concentrations at the membrane
would need to be in order to explain the observed data if glucose
concentration at the membrane were the only explanation for the
observed data. It was determined that if GLUT1 had a KM 3 mmol/l,
a membrane concentration equivalent to 10% of the arterial glucose
concentration would be necessary for the observed and predicted
curves to overlap. Some reports indicate a higher KM for GLUT1 of
17 mmol/l and in this case a membrane concentration equivalent to
50% of the arterial glucose concentration would be necessary for
the observed and predicted curves to overlap.Arterial glucose concentration (mmol/l)
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Fig. 2. Transfer of D-glucose from the maternal circulation to the fetal circulation vs
predicted glucose uptake. The linear relationship between maternal arterial glucose
concentration and experimental transfer (R2 ¼ 0.74) suggests that there is no trans-
porter saturation. The experimental data and predicted data were signiﬁcantly
different (P < 0.01). Experimental data is mean and SEM, n ¼ 5 perfusions per point.5.3. Clearance of L-glucose and 3H-3MG
Clearance of 14C-L-glucose from thematernal circulation into the
fetal circulation was not affected by either maternal (P ¼ 0.99) or
fetal (P ¼ 0.60) glucose concentrations, n ¼ 5 placentas (Fig. 3A).
Fetal to maternal L-glucose clearance was signiﬁcantly higher than
maternal to fetal clearance, n ¼ 5 placentas (P ¼ 0.03). There were
no signiﬁcant interactions between the factors (P > 0.82 in all
cases).
Clearance of 3H-3MG from thematernal circulation into the fetal
circulation was not affected by either maternal (P ¼ 0.31) or fetal
(P ¼ 0.09) glucose concentrations (Fig. 3B). Clearance of 3H-3MG in
the maternal to fetal direction was higher than in the fetal to
maternal directions (P ¼ 0.03). There were no signiﬁcant in-
teractions between the factors (P > 0.18 in all cases).
Transporter mediated clearance of 3H-3MG was not affected by
either maternal (P¼ 0.94) or fetal (P¼ 0.89) glucose concentrations
(Fig. 3C). Transporter mediated clearance from the maternal to the
fetal circulation was signiﬁcantly greater than from the fetal to the
maternal circulation (P ¼ 0.001). There were no signiﬁcant in-
teractions between the factors (P > 0.90 in all cases).
6. Discussion
This study found that placental clearance of the non-
metabolisable glucose analogue 3H-3MG from the maternal to
fetal circulation or from the fetal to maternal circulation was not
inhibited by increasing D-glucose concentrations to well above
physiological concentrations. These observations are in line with
previous studies but in apparent contrast with the pattern of
transfer we predicted using simple Michaelis Menten kinetics
[3,10,12,13]. These predictions were based on a number of as-
sumptions, including that donor side glucose concentrations were
homogeneous and equal to the arterial concentrations. The exper-
imental data suggest that there are factors that we did not initially
consider which affect the kinetics of placental glucose transfer.
The difference between the observed and predicted glucose and
3H-3MG transfer could be explained if the reported KM for GLUT1 is
lower than the actual KM. While the KM for glucose transport by
GLUT1 is generally believed to be around 3 mmol/l, values of up to
17mmol/l have been reported (equivalent to GLUT2 on Fig.1A). If the
KM for GLUT1 was 17 mmol/l this would not in itself explain our
observations although the difference would be smaller. However, a
higher intracellular KM in combination with a lower glucose con-
centration at the membrane could explain the difference. The
intracellular face of GLUT1 is reported to have a 2.9 fold lower afﬁnity
for glucose under zero-trans conditions (intracellular KM 4.6 mmol/l
vs extracellular KM 1.6 mmol/l) [18]. In order to be transferred to the
fetus, glucose must cross the BM from the intracellular side so a
higher intracellular KM may also in part explain our observations.
If these observations were to be explained by glucose concen-
trations alone then if concentrations at the MVM were 10%e50%
(depending on the actual KM for GLUT1) of those in the maternal
artery then the predicted and observed transfers would match.
Factors which reduce the glucose concentration at the membrane
compared to arterial blood include the efﬁciency of mixing of
glucose rich arterial blood with glucose depleted blood, diffusion
across the unstirred layer around the villi and the progressive
transport of glucose out of maternal blood as it passes through the
intervillous space.
Mixing of maternal blood is a particularly important determi-
nant of the glucose available for transport. The A-V difference
across the intervillous space (at maternal and fetal arterial glucose
concentrations of 6 and 3 mmol/l respectively) was 11% suggesting
that glucose concentrations within the intervillous space remain
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Fig. 3. Clearance of (A) L-glucose, (B) 3H-3MG and (C) transporter mediated 3H-3MG from the (i) maternal and (ii) fetal circulations of the isolated perfused human placental
cotyledon. A, Maternal or fetal D-glucose concentrations did not affect L-glucose clearance nor did the direction of transfer. B, Clearance of 3H-3MG was not affected by maternal or
fetal D-glucose concentrations but was higher in the maternal to fetal direction (P ¼ 0.03). C, Transporter mediated clearance (3H-3MG transfer e 14C-L-glucose). Maternal or fetal D-
glucose concentrations did not affect transporter mediated 3H-3MG clearance but this was greater in the maternal to fetal direction (P ¼ 0.001). Data is mean and SEM, n ¼ 4e5
perfusions at each point.
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villous space, a regionwherematernal blood did not mix effectively
on its way to the vein, then effective glucose concentrations may be
lower than implied by venous concentrations [19].
The human placenta is postulated to have a multivillous
arrangement of maternal and fetal blood ﬂow although this has not
been determined experimentally [20]. Under some circumstances a
multivillous blood ﬂow system could allow for solute concentra-
tions in the fetal vein to be higher than in the maternal vein even
though transfer is by diffusion [20]. In the perfusion model the
normal patterns of maternal blood ﬂow may not represent those
in vivo and this may affect the observed transfer. The perfused
placenta may have a lower ﬂow rate and viscosity which may affect
mixing within the intervillous space and therefore the glucose
concentrations at the membrane. This means we cannot assume
that our data will be directly comparable to the in vivo situation.
Blood ﬂows through the intervillous space but at the ﬂuid tissue
interface there will be an unstirred layer through which glucosemust diffuse (Fig. 4). As glucose will be transported across the
membrane on the other side of this layer, the balance between the
rate at which glucose can diffuse in and the rate at which it is
transported out will determine the concentration at themembrane.
These factors are likely to cause the glucose concentration at the
membrane to be lower than in the artery as well as regional dif-
ferences across the placenta. For this reason, the kinetics of transfer
at the MVM should ideally be worked out using a spatial mean, an
average glucose concentration across the surface of the placental
exchange area.
Placental glucose metabolism would decrease transfer rate of
D-glucose by decreasing its intracellular concentration and there-
fore affecting its transfer kinetics. As 3MG is not phosphorylated
its transfer represents glucose transfer activity independent of
placental metabolism and in this regard it will be different from
D-glucose or 2-deoxyglucose transfer.
As GLUT1 protein abundance and activity are lower on the BM,
the Vmax of the BM will be lower than that of the MVM and thus, as
Fig. 4. Factors which may affect glucose transfer kinetics across the human placenta. Glucose will diffuse, or be transported by facilitative transporters from regions of high to low
concentration. Maternal diet and hepatic glucose release keep maternal glucose high while fetal consumption reduces fetal levels. Glucose concentrations decrease progressively
from the maternal artery to vein and from [glucose]A > [glucose]B > [glucose]C >. > [glucose]H (note that [glucose]B may vary in different regions of the placenta). The glucose
concentration in any region will be determined by the rate at which glucose diffuses out in the fetal direction and the rate at which new glucose diffuses in from the maternal side.
Glucose metabolism within the syncytiotrophoblast and uptake by other placental cells will also affect glucose concentrations in speciﬁc regions. It should be noted that there is no
ﬁxed relationship between the direction of maternal blood ﬂow and blood ﬂow within the villi.
P.E. Day et al. / Placenta 34 (2013) 953e958 957has been suggested previously, it is likely that the BM will be rate-
limiting for glucose transport [4,10]. Given that glucose concen-
trations at the intracellular face of the BM will be lower than at the
MVM and that the intracellular KMmay be higher, the BMmay have
a signiﬁcant inﬂuence on the kinetics of glucose transfer (Fig. 4).
Previous theoretical studies have developed models of glucose
transport and to fully explain our observations the modelling
approach needs to be developed further in combination with
experimental studies [21]. We have previously used an approach
which couples modelling with experimental data to study amino
acid transfer and the similar development of an experimentally
validated model for glucose transfer would also prove useful
[22,23]. While there is an extensive literature on the KM for GLUT1
and most studies suggest a KM around 3 mmol/l there is wide
discrepancy in the literature [7,8]. Further data on both intracel-
lular and extracellular KM for GLUT1, preferably obtained under
equilibrium exchange conditions, would be very helpful in this
regard.
6.1. Paracellular diffusion
We found signiﬁcant unidirectional paracellular ﬂuxes of
L-glucose which suggests a signiﬁcant capacity for transfer of
glucose by paracellular diffusion. However it should be noted
that paracellular diffusion in the perfusion system may be higher
than in-vivo as has been suggested from studies in guinea pigs
[24,25]. In contrast to a previous study where L-glucose ﬂux was
greatest in the fetal to maternal direction we did not see any
difference in the clearance of L-glucose in either direction [10].
This may reﬂect differences in the placental perfusion setup
between laboratories.7. Conclusion
The fact that the predicted and experimental glucose transfer
kinetics did not match suggests that factors we did not initially
consider are important determinants of placental glucose transfer.
This illustrates the need for a systems biology approach to under-
standing the kinetics of placental glucose transport and the
importance of understanding transporter activity in its physiolog-
ical context. Understanding the determinants of placental glucose
transfer is important if we are to explain how glucose transfer may
be affected in pathological pregnancies with either fetal growth
restriction or fetal macrosomia.
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